Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40

Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40

US Patent 11136406 · Granted Oct 5, 2021

Estimated economic value: $581,764,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glypican-3-binding fibronectin based scaffold molecules2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Anti P2X7 receptor antibodies and fragments thereof2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Compositions monovalent for CD28 binding and methods of use2024
Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding pr2024
Nucleic acids encoding anti-TREM-1 antibodies2024